カテゴリ： GlobalData, インド, 企業調査

Meril Life Sciences Pvt Ltd：企業の製品パイプライン分析2018

◆英語タイトル：Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12182
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：33
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. It offers coronary drug eluting stents, coronary bare metal stents, PTCA balloon dilatation catheter, bioresorbable scaffold, trans-catheters, knee systems and acetabular cup systems, IVD analyzers and reagents, surgical sutures, tissue sealants, absorbable hemostats, mesh, intra uterine devices, access devices, lab consumables, energy devices and staplers, accessories, and others. The company markets its products through direct sales, distributors and representatives offices located in India, Germany, Turkey, the US, China and Brazil. Meril is headquartered in Vapi, Gujarat, India.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Meril Life Sciences Pvt Ltd Company Overview 5
Meril Life Sciences Pvt Ltd Company Snapshot 5
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Meril Life Sciences Pvt Ltd – Pipeline Analysis Overview 7
Meril Life Sciences Pvt Ltd – Key Facts 7
Meril Life Sciences Pvt Ltd – Major Products and Services 8
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12
Meril Life Sciences Pvt Ltd Pipeline Products Overview 15
BioMime 15
BioMime Product Overview 15
BioMime Clinical Trial 16
BIOMIME AURA 18
BIOMIME AURA Product Overview 18
BIOMIME AURA Clinical Trial 19
Credence – Peripheral BRS 20
Credence – Peripheral BRS Product Overview 20
Credence – Peripheral BRS Clinical Trial 21
Crypton Stainless Steel Coronary Stent System 22
Crypton Stainless Steel Coronary Stent System Product Overview 22
MeRes100 23
MeRes100 Product Overview 23
MeRes100 Clinical Trial 24
Myval Transcatheter Aortic Valve Replacement System 25
Myval Transcatheter Aortic Valve Replacement System Product Overview 25
NEXGEN Cobalt Chromium Coronary Stent System 26
NEXGEN Cobalt Chromium Coronary Stent System Product Overview 26
Meril Life Sciences Pvt Ltd – Key Competitors 27
Meril Life Sciences Pvt Ltd – Key Employees 28
Meril Life Sciences Pvt Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type 6
Meril Life Sciences Pvt Ltd Pipeline Products by Indication 6
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 6
Meril Life Sciences Pvt Ltd, Key Facts 7
Meril Life Sciences Pvt Ltd, Major Products and Services 8
Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage 11
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary 13
BioMime - Product Status 15
BioMime - Product Description 15
BioMime - A Prospective, Active Control Open Label, Multicenter Randomized Clinical Trial for Comparison Between BioMime Sirolimus Eluting Stent of and Xience Everolimus Eluting Stent to Evaluate Efficacy and Safety in Coronary Artery Disease 16
BioMime - A Prospective, Active Control, Open-label, Multi-center, Randomized Clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System Versus Xience family of Everolimus Eluting Coronary Stent System to Evaluate Safety and Performance in Patients with de Novo Coronary Bifurcation Lesions 16
BioMime - A Prospective, Single-arm, Multi-center, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions. 16
BioMime - Biomime Biosorbable Polymer Sirolimus-eluting Stent in All-comers Patients Treated with Percutaneous Coronary Interventions: The BELLINI Registry 17
BioMime - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent Versus 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 17
BioMime - Real World Drug-eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMime Stent, Ultimaster Stent Versus Xience Stent by SMart Angioplastry Research Team: SMARTDESK-MX 17
BIOMIME AURA - Product Status 18
BIOMIME AURA - Product Description 18
BIOMIME AURA - A Prospective, Active Control, Open-label, Multi-center, Randomized Clinical trial comparing BioMime Branch - Sirolimus Eluting Coronary Side Branch Stent System Versus Xience family of Everolimus Eluting Coronary Stent System to Evaluate Safety and Performance in Patients with de Novo Coronary Bifurcation Lesions 19
BIOMIME AURA - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent Versus 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 19
Credence - Peripheral BRS - Product Status 20
Credence - Peripheral BRS - Product Description 20
Credence - Peripheral BRS - A Prospective, Multicentered and Open Label Clinical Study to Evaluate Safety and Performance of Credence Btk Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Following Percutaneous Transluminal Angioplasty of Below the Knee Arteries 21
Credence - Peripheral BRS - Credence BRS 1: A Prospective, Open Label and Multicentric Clinical Study to Evaluate Safety and Performance of Credence BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with De Novo Native Peripheral Artery Lesions 21
Crypton Stainless Steel Coronary Stent System - Product Status 22
Crypton Stainless Steel Coronary Stent System - Product Description 22
MeRes100 - Product Status 23
MeRes100 - Product Description 23
MeRes100 - A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes - China 24
MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend) 24
Myval Transcatheter Aortic Valve Replacement System - Product Status 25
Myval Transcatheter Aortic Valve Replacement System - Product Description 25
NEXGEN Cobalt Chromium Coronary Stent System - Product Status 26
NEXGEN Cobalt Chromium Coronary Stent System - Product Description 26
Meril Life Sciences Pvt Ltd, Key Employees 28
Meril Life Sciences Pvt Ltd, Other Locations 29
Meril Life Sciences Pvt Ltd, Subsidiaries 29
Glossary 32

List of Figures
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type 6
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage 10
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[Meril Life Sciences Pvt Ltd：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Fairfax Media Limited：戦略・SWOT・企業財務分析
    Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Natera Inc (NTRA)-医療機器分野：企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • The Michaels Companies, Inc.：企業の戦略・SWOT・財務情報
    The Michaels Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Michaels Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Itamar Medical Ltd (ITMR)：企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. It develops products using its proprietary peripheral arterial tonometry (PAT) …
  • Intellipharmaceutics International Inc (IPCI)：企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Societe Anonyme Belge de Constructions Aeronautiques：企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • DiaMedica Therapeutics Inc (DMA)：医療機器：M&Aディール及び事業提携情報
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Energy Recovery Inc (ERII)：企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Histogen Inc-製薬・医療分野：企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …
  • CMA CGM SA：戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • R-Biopharm AG：医療機器：M&Aディール及び事業提携情報
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical di …
  • Totally Plc (TLY)：企業の財務・戦略的SWOT分析
    Summary Totally Plc (Totally) is a healthcare service provider that offers positive health and financial solutions. The center designs, implements and delivers coaching services to the healthcare sector, and supports individuals to better understand their healthcare options. It offers treatments and …
  • Sanara MedTech Inc (WNDM)：企業の財務・戦略的SWOT分析
    Summary Sanara MedTech Inc (Sanara MedTech), formerly WNDM Medical Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its pro …
  • Alpiq Holding AG：企業の戦略的SWOT分析
    Alpiq Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ohr Pharmaceutical Inc (OHRP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Biomay AG-製薬・医療分野：企業M&A・提携分析
    Summary Biomay AG (Biomay) discovers and develops disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. Its pipeline product portfolio comprises investigation candidates targeted against IgE mediated diseases, grass pollen allergy, ho …
  • The Saudi British Bank (1060)：企業の財務・戦略的SWOT分析
    The Saudi British Bank (1060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Camargo Correa Sa
    Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report Summary Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Abionic SA：医療機器：M&Aディール及び事業提携情報
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone and iPad, and accessories, among others. Its abioSCOPE in vitr …
  • Grupo Financiero Galicia SA (GGAL3)：企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia SA (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆